Question for you guys. Do you let fundamental analysis and most recent news interfere with your technical analysis driven decissions? Why am I saying this? Because GNVC(the stock that playa brought to our attention) lost half of it's value on, not FDA disapproval, but just request for more data. Considering that they have (I think 2) products in their pipeline that's obviously an overeaction on the sellers part.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.